Inactive Instrument

Insiders Windtree Therapeutics Inc Nasdaq

Equities

US97382D1054

Insiders

Unlock all the news: Be the first to know and act before the market!

Windtree Therapeutics, Inc. Announces Resignation of John A. Tattory as Interim Chief Financial Officer and Principal Financial Officer	17/02	CI
Windtree Therapeutics, Inc. Announces Resignation of John A. Tattory as Principal Financial Officer	17/02	CI
Windtree Therapeutics, Inc. Appoints Jamie McAndrew as Controller, Chief Accounting Officer and Principal Accounting Officer	29/23/29	CI
Windtree Therapeutics, Inc. Appoints Mark Strobeck to its Board of Directors	27/23/27	CI
Windtree Therapeutics Chair James Huang Resigns; Shares Sink Premarket	19/23/19	MT
Windtree Therapeutics, Inc. Announces Chief Financial Official Officer Changes	19/23/19	CI
Windtree Therapeutics, Inc. Announces Executive Changes	19/23/19	CI
Windtree Therapeutics, Inc. Announces Not Stand for Re-Election of Evan Loh from Board	12/22/12	CI
Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel	01/21/01	CI
Windtree Therapeutics, Inc. Announces Bruce Peacock, A Member of the Board of Directors Not to Stand for Re-Election	01/21/01	CI
Insider Trends: Windtree Therapeutics Insider Buy Scaling Back 90-Days of Sells	03/21/03	MT
Windtree Therapeutics, Inc. Announces Executive Changes	04/21/04	CI
Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development	02/21/02	CI
Windtree Therapeutics, Inc. Announces Executive Appointment	21/20/21	CI
Windtree Therapeutics, Inc. Appoints John Hamill as Senior Vice President	20/20/20	CI
Windtree Therapeutics, Inc. Appoints John Hamill as Chief Financial Officer	20/20/20	CI
Windtree Therapeutics, Inc. Appoints Eric Curtis as Senior Vice President and Chief Operating Officer	13/20/13	CI
Windtree Therapeutics, Inc. Appoints Daniel Geffken to its Board of Directors	30/19/30	CI
Windtree Therapeutics, Inc. Announces Executive Appointments	22/18/22	CI
Windtree Therapeutics, Inc. Announces Demise of Marvin E. Rosenthale, Chairman of the Board's Nomination and Governance Committee and a Member of the Audit Committee	17/18/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Windtree Therapeutics Inc Nasdaq

Equities

US97382D1054

Insiders

Filters